• Publications
  • Influence
Serum Bactericidal Antibody Responses to Meningococcal Polysaccharide Vaccination as a Basis for Clinical Classification of Common Variable Immunodeficiency
TLDR
It is concluded that individuals with CVID who cannot produce protective postvaccination titers after receiving meningococcal polysaccharide vaccine are more likely to exhibit bronchiectasis, splenomegaly, and autoimmune diseases.
Serological Evaluation of Brucella abortus S99 Lipopolysaccharide Extracted by an Optimized Method
TLDR
The possible use of this component of B. abortus as a carrier or a part of a sub-unit or conjugated vaccine for human brucellosis is suggested.
Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies.
TLDR
It is indicated that some patients withPrimary antibody deficiencies can produce protective post-vaccination titres similar to the normal population, despite the common perception that patients with primary antibody deficiencies respond poorly to vaccination.
Immune reactivity of Brucella melitensis–vaccinated rabbit serum with recombinant Omp31 and DnaK proteins
TLDR
It was proved that immunized serum contains antibodies against recombinant Omp31 (rOmp31) and DnaK (rDnaK) by Western blot and ELISA assays, suggesting the importance of these proteins as subunit vaccines against B. melitensis as well as targets for immunotherapy.
Biocontrol of Shigella flexneri in Ground Beef and Vibrio cholerae in Seafood with Bacteriophage-Assisted High Hydrostatic Pressure (HHP) Treatment
TLDR
A combination of HHP and VP as an efficacious hurdle technology for meat and seafood processing is indicated.
Immunogenicity assessment of Brucella mellitensis HSP and TF proteins by immunized rabbit serum.
TLDR
This research attacked the mode of action of Bacterial Vaccines and Antigen Production by targeting the “spatially aggregating” mechanism and found it to be a “drug-free” process.
Optimization and Efficient Purification in Production of Brucella melitensis Recombinant HSP and TF Proteins With Low Endotoxin Contents
Background: The development of an effective subunit vaccine against brucellosis is a research area of intense. But optimization of recombinant proteins production in Escherichia coli and content of
Immunological evaluation of OMP-F of native Iranian Pseudomonas aeruginosa as a protective vaccine.
TLDR
Investigations indicate that purified OMP-F of CSBPI: 16-190 can be regarded as a safe protective immunogen in vaccinothrapy against all P. aeruginosa serotypes with 50-100% level of protection.
Immunological evaluation of Vi capsular polysaccharide of Salmonella enterica subsp. Typhi vaccine by serum bactericidal assay.
TLDR
Vi-CPS was shown to be a potent immunogen, as even one dose could induce an efficient bactericidal effect against S. Typhi.
...
1
2
3
...